These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 386613

  • 1. Evaluation of the 'Mason' (continuous-thaw-siphon) method for cryoprecipitate production.
    Prowse CV, McGill A.
    Vox Sang; 1979; 37(4):235-43. PubMed ID: 386613
    [Abstract] [Full Text] [Related]

  • 2. An improved thaw-siphon method for the cryoprecipitate preparation.
    Kang EP.
    Vox Sang; 1980; 38(3):172-7. PubMed ID: 6770544
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vivo characteristics of thaw siphon cryoprecipitate compared to other factor VIII preparations.
    Toolis F, McKay G, Prowse CV.
    Thromb Haemost; 1980 Feb 29; 43(1):25-7. PubMed ID: 6773169
    [Abstract] [Full Text] [Related]

  • 6. A novel modified thaw-siphon method for extracting cryoprecipitate: The Bokutoh-siphon method.
    Nishimura S, Teratani M, Igarashi T, Nakahara M, Hazama Y, Ohtani S, Fujita H.
    Transfusion; 2021 Apr 29; 61(4):1035-1040. PubMed ID: 33634868
    [Abstract] [Full Text] [Related]

  • 7. Control of large-scale plasma thawing for recovery of cryoprecipitate factor VIII.
    Foster PR, Dickson AJ, McQuillan TA, Dickson IH, Keddie S, Watt JG.
    Vox Sang; 1982 Apr 29; 42(4):180-9. PubMed ID: 6806984
    [Abstract] [Full Text] [Related]

  • 8. Microwave-thawed plasma for cryoprecipitate production.
    Bass H, Trenchard PM, Mustow MJ.
    Vox Sang; 1985 Apr 29; 48(2):65-71. PubMed ID: 3934842
    [Abstract] [Full Text] [Related]

  • 9. [Preparation of a cryoprecipitate by the thaw and siphon method].
    Daszyński J, Rosiek A, Lopaciuk S.
    Acta Haematol Pol; 1985 Apr 29; 16(3-4):139-43. PubMed ID: 3939069
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Contribution to the optimal use of human blood. VII. Increase of the yield of factor VIII in four-donor cryoprecipitate by an improved processing of blood and plasma.
    Vermeer C, Soute BA, Ates G, Brummelhuis HG.
    Vox Sang; 1976 Apr 29; 30(1):1-22. PubMed ID: 1251567
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Determinants of factor VIII recovery in cryoprecipitate.
    Kasper CK, Myhre BA, McDonald JD, Nakasako Y, Feinstein DI.
    Transfusion; 1975 Apr 29; 15(4):312-22. PubMed ID: 1166504
    [Abstract] [Full Text] [Related]

  • 18. A protocol for cryoprecipitate production.
    Burka ER, Harker LA, Kasper CK, Kevy SV, Ness PM.
    Transfusion; 1975 Apr 29; 15(4):307-11. PubMed ID: 1166503
    [Abstract] [Full Text] [Related]

  • 19. Thaw-siphon technique for factor-VIII cryoprecipitate.
    Das PC, Smit Sibinga CT.
    Lancet; 1978 Jul 29; 2(8083):273. PubMed ID: 79076
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.